These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 9021114

  • 1. Metabolic myocardial viability assessment with iodine 123-16-iodo-3-methylhexadecanoic acid in recent myocardial infarction: comparison with thallium-201 and fluorine-18 fluorodeoxyglucose.
    Vanzetto G, Janier M, Fagret D, Cinotti L, André-Fouet X, Comet M, Machecourt J.
    Eur J Nucl Med; 1997 Feb; 24(2):170-8. PubMed ID: 9021114
    [Abstract] [Full Text] [Related]

  • 2. Assessment of myocardial viability in patients with previous myocardial infarction by using single-photon emission computed tomography with a new metabolic tracer: [123I]-16-iodo-3-methylhexadecanoic acid (MIHA). Comparison with the rest-reinjection thallium-201 technique.
    Marie PY, Angioï M, Danchin N, Olivier P, Virion JM, Grentzinger A, Karcher G, Juillière Y, Fagret D, Cherrier F, Bertrand A.
    J Am Coll Cardiol; 1997 Nov 01; 30(5):1241-8. PubMed ID: 9350922
    [Abstract] [Full Text] [Related]

  • 3. Course of impaired left ventricular function after acute myocardial infarction predicted with planar thallium-201 chloride and F18-fluorodeoxyglucose imaging.
    Huitink JM, Visser FC, Bax JJ, van Lingen A, Visser CA.
    Int J Cardiol; 1996 Dec 13; 57(3):271-81. PubMed ID: 9024916
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Thallium-201 rest-reinjection and iodine-123-MIHA imaging of myocardial infarction: analysis of defect reversibility.
    Marie PY, Karcher G, Danchin N, Olivier P, Angioï M, Juillière Y, Grentzinger A, Fagret D, Cherrier F, Bertrand A.
    J Nucl Med; 1995 Sep 13; 36(9):1561-8. PubMed ID: 7658210
    [Abstract] [Full Text] [Related]

  • 6. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography.
    Dilsizian V, Perrone-Filardi P, Arrighi JA, Bacharach SL, Quyyumi AA, Freedman NM, Bonow RO.
    Circulation; 1993 Sep 13; 88(3):941-52. PubMed ID: 8353921
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease.
    Rossetti C, Landoni C, Lucignani G, Huang G, Bartorelli AL, Guazzi MD, Margonato A, Chierchia S, Galli L, Savi A.
    Eur J Nucl Med; 1995 Nov 13; 22(11):1306-12. PubMed ID: 8575482
    [Abstract] [Full Text] [Related]

  • 12. Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201Tl defects.
    Brunken RC, Mody FV, Hawkins RA, Nienaber C, Phelps ME, Schelbert HR.
    Circulation; 1992 Nov 13; 86(5):1357-69. PubMed ID: 1423947
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of reverse redistribution on 24-hour delayed imaging of exercise thallium-201 myocardial SPECT: comparison with myocardial fluorine-18-FDG-PET imaging and left ventricular wall motion.
    Ohte N, Hashimoto T, Banno T, Narita H, Kobayashi K, Akita S, Fujinami T.
    J Nucl Med; 1995 Jan 13; 36(1):86-92. PubMed ID: 7799089
    [Abstract] [Full Text] [Related]

  • 14. Thallium-201 reinjection images can identify the viable and necrotic myocardium similarly to metabolic imaging with glucose loading 18F-fluorodeoxyglucose (18FDG)-PET.
    Ogiu N, Nakai K, Hiramori K.
    Ann Nucl Med; 1994 Aug 13; 8(3):171-6. PubMed ID: 7811558
    [Abstract] [Full Text] [Related]

  • 15. Regional left ventricular wall thickening. Relation to regional uptake of 18fluorodeoxyglucose and 201Tl in patients with chronic coronary artery disease and left ventricular dysfunction.
    Perrone-Filardi P, Bacharach SL, Dilsizian V, Maurea S, Frank JA, Bonow RO.
    Circulation; 1992 Oct 13; 86(4):1125-37. PubMed ID: 1394920
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.
    Dilsizian V, Arrighi JA, Diodati JG, Quyyumi AA, Alavi K, Bacharach SL, Marin-Neto JA, Katsiyiannis PT, Bonow RO.
    Circulation; 1994 Feb 13; 89(2):578-87. PubMed ID: 8313546
    [Abstract] [Full Text] [Related]

  • 18. Head-to-head comparison of 201Tl rest-redistribution scintigraphy and stress-immediate reinjection scintigraphy in the detection of myocardial viability.
    van Eck-Smit BL, van der Wall EE, Siebelink HM, Baur LH, Zwinderman AH, Pauwels EK.
    Nucl Med Commun; 1996 Mar 13; 17(3):216-24. PubMed ID: 8692489
    [Abstract] [Full Text] [Related]

  • 19. Regional uptake of [123I]-16-iodo3-R,S-methyl hexadecanoic acid in patients with myocardial infarction. Comparison with thallium 201 uptake and wall motion.
    Fagret D, Rocca C, Machecourt J, Wolf JE, Dubois F, Mathieu JP, Comet M.
    Am J Card Imaging; 1994 Jan 13; 8(1):1-7. PubMed ID: 8130610
    [Abstract] [Full Text] [Related]

  • 20. Viable myocardium identified by reinjection thallium-201 imaging: comparison with regional wall motion and metabolic activity on FDG-PET.
    Tamaki N, Ohtani H, Yonekura Y, Shindo M, Nohara R, Kambara H, Kawai C, Hirata K, Ban T, Konishi J.
    J Cardiol; 1992 Jan 13; 22(2-3):283-93. PubMed ID: 1339787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.